The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

mTOR inhibitors

mTOR inhibitors

mTOR inhibitors inhibit the mammalian target of rapamycin (mTOR) by forming a complex with binding proteins and preventing the phosphorylation of mTOR substrates. The inhibition of mTOR leads to cell cycle arrest and inhibits angiogenesis. The mTOR inhibitor, temsirolimus, is approved for the treatment of relapsed or refractory mantle cell lymphoma (MCL).

|||

All Interventions